Sorrento Therapeutics, Inc. Uncategorized Contracts & Agreements
40 Contracts & Agreements
- Manufacturing Technology Transfer Agreement, dated November 2, 2023, between Yuhan Corporation and Sorrento Therapeutics, Inc (Filed With SEC on November 3, 2023)
- Amendment No. 1 to Sponsor Support Agreement, dated as of September 12, 2022, by and among Vickers Vantage Corp. I, Scilex Holding Company and each of the Persons set forth on... (Filed With SEC on September 14, 2022)
- Stockholder Agreement, dated as of September 12, 2022, by and among Sorrento Therapeutics, Inc. and Vickers Vantage Corp. I (Filed With SEC on September 14, 2022)
- Offer Letter, dated April 27, 2022, between Scilex Holding Company and Elizabeth A. Czerepak (Filed With SEC on April 28, 2022)
- Offer Letter, dated April 27, 2022, between Sorrento Therapeutics, Inc. and Elizabeth A. Czerepak (Filed With SEC on April 28, 2022)
- Company Stockholder Support Agreement, dated as of March 17, 2022, by and among Sorrento Therapeutics, Inc., Scilex Holding Company and Vickers Vantage Corp. I (Filed With SEC on March 18, 2022)
- Sponsor Support Agreement, dated as of March 17, 2022, by and among Vickers Vantage Corp. I and each of the Persons set forth on Schedule I attached thereto (Filed With SEC on March 18, 2022)
- Description of Securities of Sorrento Therapeutics, Inc (Filed With SEC on March 11, 2022)
- Contract, dated August 15, 2018, by and between Hangzhou ACEA Pharmaceutical Research Co., Ltd. and ACEA Bio (Hangzhou) Co., Ltd. (translated into English from its original text... (Filed With SEC on June 4, 2021)
- Earn-Out Agreement, dated June 1, 2021, by and between Sorrento Therapeutics, Inc. and Fortis Advisors LLC (Filed With SEC on June 4, 2021)
- Description of Securities of Sorrento Therapeutics, Inc (Filed With SEC on February 19, 2021)
- Description of Securities of Sorrento Therapeutics, Inc (Filed With SEC on March 3, 2020)
- Collateral Agreement, dated as of September 7, 2018, by and between Scilex Pharmaceuticals Inc. and U.S. Bank National Association, as trustee and collateral agent (Filed With SEC on November 9, 2018)
- Offer Letter, dated March 15, 2018, by and between Sorrento Therapeutics, Inc. and Jiong Shao (Filed With SEC on May 10, 2018)
- [Signature Page Follows] (Filed With SEC on August 8, 2016)
- OPTION AGREEMENT (Filed With SEC on March 15, 2016)
- SORRENTO THERAPEUTICS, INC. and PHILADELPHIA STOCK TRANSFER, INC., Rights Agent Amended and Restated Rights Agreement Dated asof December 21, 2015 TABLE OF CONTENTS (Filed With SEC on December 21, 2015)
- STOCKHOLDERS AGREEMENT dated as of December23, 2014 by and among CONKWEST, INC., SORRENTO THERAPEUTICS, INC., CAMBRIDGE EQUITIES, LP and THE PERSONS LISTEDON SCHEDULE A HERETO... (Filed With SEC on December 29, 2014)
- SORRENTO THERAPEUTICS, INC. and PHILADELPHIA STOCK TRANSFER, INC., Rights Agent Amended and Restated Rights Agreement Dated asof December 22, 2014 1 TABLE OF CONTENTS (Filed With SEC on December 23, 2014)
- AMENDMENT #7 (Filed With SEC on August 6, 2014)
- SORRENTO THERAPEUTICS, INC. and COMPUTERSHARE TRUST COMPANY, N.A., Rights Agent Rights Agreement Dated as of November 7, 2013 TABLE OF CONTENTS (Filed With SEC on November 12, 2013)
- EXCLUSIVE OPTION AGREEMENT by and between B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., an Israeli Company and SORRENTO THERAPEUTICS, INC., a Delaware (US) corporation EXCLUSIVE... (Filed With SEC on August 13, 2013)
- OPTION AGREEMENT Dated as of March 7, 2013 by and between SORRENTO THERAPEUTICS, INC. and IGDRASOL, INC. TABLE CONTENTS (Filed With SEC on May 15, 2013)
- AMENDMENT #6 (Filed With SEC on August 14, 2012)
- AMENDMENT #5 (Filed With SEC on March 30, 2012)
- AMENDMENT #4 (Filed With SEC on March 30, 2012)
- AMENDMENT #3 (Filed With SEC on March 30, 2012)
- AMENDMENT #4 (Filed With SEC on March 18, 2011)
- AMENDMENT #3 (Filed With SEC on March 18, 2011)
- SORRENTO THERAPEUTICS, INC. 2009 EQUITY INCENTIVEPLAN Approved by the Board of Directors: February 5, 2009 (Filed With SEC on March 25, 2010)
- AMENDMENT #2 (Filed With SEC on March 25, 2010)
- SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE CT.WEST, SUITE B SAN DIEGO, CA 92121, USA (Filed With SEC on March 25, 2010)
- AMENDMENT #2 (Filed With SEC on November 12, 2009)
- SORRENTO THERAPEUTICS, INC. INDEMNITY AGREEMENT (Filed With SEC on October 23, 2009)
- SORRENTO THERAPEUTICS, INC. TRANSFER FEE $25.00 (Filed With SEC on October 23, 2009)
- PLAN OF CONVERSION OF QuikByte Software, Inc., aColorado corporation, INTO QuikByte Software, Inc., a Delaware corporation (Filed With SEC on October 23, 2009)
- QuikByte Software, Inc. 4400 Biscayne Boulevard, Suite 950 Miami, Florida 33137 (Filed With SEC on September 21, 2009)
- QuikByte Software, Inc. 4400 Biscayne Boulevard, Suite 950 Miami, Florida 33137 (Filed With SEC on September 21, 2009)
- LOCK-UP AGREEMENT (Filed With SEC on September 21, 2009)
- AGREEMENT (Filed With SEC on March 26, 2007)
